The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Barbara Eichhorst Stephan Stilgenbauer Clemens-Martin Wendtner Michael Hallek Jasmin Bahlo |
| Publication date | July 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |